RT Journal Article
T1 Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
A1 Cordero, Elisa
A1 Goycochea Valdivia, Walter
A1 Mendez Echevarría, Ana
A1 Allende, Luis
A1 Alsina, Laia
A1 Bravo García Morato, María
A1 Gil Herrera, Juana
A1 Gudiol, Carlota
A1 Len Abad, Óscar
A1 López Medrano, Francisco
A1 Moreno Pérez, David
A1 Muñoz, Patricia
A1 Olbrich, Peter
A1 Sánchez Ramón, Silvia María
A1 Soler Paracín, Pere
A1 Aguilera Cros, Clara
A1 Arostegui, Juan Ignacio
A1 Badell Serra, Isabel
A1 Carbone Campoverde, Javier Alberto
A1 Fortún, Jesús
A1 González Granado, Luis Ignacio
A1 López Granados, Eduardo
A1 Lucena, José Manuel
A1 Parody, Rocío
A1 Ramakers, Jan
A1 Regueiro González-Barros, José Ramón
A1 Rivière, Jacque G
A1 Roca Oporto, Cristina
A1 Rodríguez Pena, Rebeca
A1 Santos Pérez, Juan Luis
A1 Rodríguez Gallego, Carlos
A1 Neth, Olaf
AB Primary immunodeficiencies (PIDs) are rare, undiagnosed and potentially fatal diseases. Clinical manifestations of PID can be fatal or leave sequelae that worsen the quality of life of patients. Traditionally, the treatment of PIDs has been largely supportive, with the exception of bone marrow transplantation and, more recently, gene therapy. The discovering of new affected pathways, the development of new molecules and biologics, and the increasing understanding of the molecular basis of these disorders have created opportunities in PIDs therapy. This document aims to review current knowledge and to provide recommendations about the diagnosis and clinical management of adults and childre  with PIDs based on the available scientific evidence taking in to account current practice and future challenges. A systematic review was conducted, and evidence levels based on the available literature are given for each recommendation where available. � 2020 American Academy of Allergy, Asthma & Immunology; Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [Published by Elsevier Inc./Elsevier Espana]. All rights reserved.
PB Elsevier
SN 2213-2198
YR 2020
FD 2020-12
LK https://hdl.handle.net/20.500.14352/8576
UL https://hdl.handle.net/20.500.14352/8576
LA eng
NO Cordero E, Goycochea-Valdivia W, Mendez-Echevarria A, Allende LM, Alsina L, Bravo García-Morato M, et al. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies. The Journal of Allergy and Clinical Immunology: In Practice 2020;8:3342–7. https://doi.org/10.1016/j.jaip.2020.05.008.
DS Docta Complutense
RD 6 abr 2025